Symptoms of atypical teratoid rhabdoid tumors (ATRT) vary depending on the patient’s age and location of the tumor. Because this type of tumor grows rapidly, symptoms appear quickly and worsen over several weeks.
Common signs and symptoms of ATRT may include:
- Nausea and vomiting
- Morning headache
- Unusual sleepiness
- Increase in the head size (in infants)
- Lack of balance and coordination or trouble walking
- Lethargy and tiredness
- Change in activity levels
- Problems with eye or facial movements
- Paralysis or weakness of the arm, leg and trunk on one side (half) of the body
- Blurred or double vision
- Change in behavior and irritability
- Increased fullness of the fontanel (“soft spot” at the top of the skull in infants)
Other signs may include pain, numbness, tingling, or other symptoms related to the presence of tumors.
What is ATRT?
ATRT is a rare type of brain tumor that is highly malignant and mostly affects children. It grows quickly and primarily affects the brain and spinal cord (central nervous system).
Rhabdoid tumors contain many large cells. There are three types of rhabdoid tumors grouped together by locations in which they originate:
- ATRT: Occurs in the brain and spinal cord
- Malignant renal rhabdoid tumor: Occurs in the kidney (renal)
- Extra renal rhabdoid tumor: Occurs elsewhere in the body such as in the liver, lungs, and skin
ATRT may be classified as follows:
- Localized: Occurring in only one location in the brain
- Metastatic: Has spread to other parts of the brain or spinal cord
- Multifocal: Tumors form in more than one place at the same time (may occur in a child who has a genetic mutation)
What are risk factors for ATRT?
Most ATRT cases are linked to genetic defects on chromosome 22. Changes in tumor suppressor genes SMARCB1 (located on chromosome 22) may be linked to ATRT (also known as INI1, SNF5, and BAF47 genes).
ATRT is caused by a defect in another tumor suppressor gene called SMARCA4 in less than 5% of cases. This type of gene produces a protein that aids in cell growth control. When the gene fails to function, the protein is not produced, and tumor growth is uncontrolled.
- ATRT affects about 1%-2% percent of all children with brain tumors.
- Infants and young children younger than 3 years of age are typically affected.
- ATRT has been found in some older children and young adults in rare cases.
- Men have a slightly higher tumor incidence than women (in a 3:2 ratio).
- People of all ethnicities may be affected.
Rhabdoid tumors can be associated with a rhabdoid tumor predisposition syndrome, which means that some children are predisposed to developing this tumor. The majority of children with rhabdoid tumors have a gene loss or mutation. Because this tumor occurs in young children or infants, some researchers believe it develops from the germ cell stage or the stem cell stage.
How is ATRT diagnosed?
In most cases, the child may have a defective gene, and genetic testing may be useful in diagnosing the brain tumor. If a patient has already shown signs of ATRT, imaging can help determine the diagnosis. Depending on the signs and symptoms, one or a combination of the following tests may be recommended:
- Computerized tomography (CT) scan
- Magnetic resonance imaging (MRI) of the brain and spine
- Blood tests
- Echocardiogram (heart scan)
- Biopsy or resection (removal) of the tumor
- Bone scan
- SMARCB1 and SMARCA4 gene testing, which is a laboratory test in which a blood or tissue sample is examined for changes in SMARCB1 and SMARCA4 genes.
- Lumbar puncture, in which a small sample of cerebrospinal fluid is extracted from the spine using a small needle. The sample is then analyzed to see if there are any tumor cells in the fluid surrounding the central nervous system.
- Ultrasound of the abdomen to ensure that all other organs are healthy and that no other tumors are present.
The most common way to confirm a diagnosis is to rely on MRI results, which are then confirmed by histopathology (brain biopsy/resection). Many clinical conditions can have symptoms that are similar to one another. To arrive at a definitive diagnosis, additional tests may be performed to rule out other clinical conditions.
- Your Child Is Sick. Do You Call Your Doctor or Head to the ER?
- Mental Health Care Shortage Could Play Role in U.S. Youth Suicides
- Shopping Black Friday for TVs, Furniture? Don't Forget the Tip-Over Kit
- Keeping Thanksgiving Day Kitchens Safe for the Whole Family
- All the Flavor, Better Health: Holiday Dinner Ingredient Swaps That Work
- More Health News »
6 treatment options for ATRT
Treatment ATRT is determined by the patient’s age and size and location of the tumor. These tumors are aggressive, and most patients receive a combination of treatment options:
- Surgery is the first line of treatment for this condition.
- A diversionary procedure for cerebrospinal fluid is usually recommended.
- The majority of children undergo a craniotomy, with the tumor resected as far as it can safely be done.
- In about 50% of patients, total or near total resection of the tumor is possible. Gross total resection is possible in 64% of patients under age 3 and in 78% of children over age 3.
- Within 3 months of surgery, 81% of patients under age 3 develop a recurrence of the disease, and recurrence is mostly local in more than 70% of patients.
- Powerful drugs are used to kill cancer cells and slow their growth, usually administered after surgery.
- Chemotherapy is administered orally or by injection directly into the bloodstream.
- Most children with ATRT receive chemotherapy at some point during their clinical course, particularly those under age 2, to postpone radiation therapy.
- Recurrent or progressive ATRT in children who are 3 years old or younger appears to be resistant to chemotherapy as compared to in older children.
3. Radiation therapy
- In radiation therapy, X-rays or other high-energy radiation are used to kill cancer cells, while preventing them from further division and growth.
- Because most children diagnosed with ATRT are under 2 years of age, radiotherapy is not initially offered due to toxicity of radiation to developing brains.
- Currently, the goal is to keep the child on chemotherapy until they are at least 2-3 years old, at which point radiation effects will be less severe.
4. High-dose chemotherapy with stem cell transplant
- High doses of chemotherapy are administered to destroy cancer cells. Healthy cells are destroyed as well, including blood-forming cells. Stem cell transplantation is used to replace the blood-forming cells.
- Stem cells (immature blood cells) are extracted from the patient's or donor's blood or bone marrow and frozen and stored.
- After the patient has finished chemotherapy, the stored stem cells are thawed and infused back into the patient. These reinfused stem cells develop into (and restore) blood cells in the body.
5. Targeted therapy
- Children with ATRT are eligible for ongoing clinical trials that involve targeted therapy, which is a type of cancer treatment in which drugs or other substances are used to specifically attack cancer cells.
- Targeted therapies are less likely to harm healthy cells than chemotherapy or radiation therapy.
- The use of targeted therapy in the treatment of recurrent ATRT is still being researched.
6. Supportive care
- Supportive care is an important part of ATRT treatment for children, with the goal being to keep the child as comfortable and symptom-free as possible.
- Supportive care includes treatment of infections, pain relief, and medication to reduce side effects such as sickness.
- In many areas, children with cancer are routinely referred to the local children's hospice team for help with symptom management while undergoing active treatment.
Participating in a clinical trial may be the best treatment option for some patients. Clinical trials are a component of cancer research. Clinical trials are conducted to determine whether new cancer treatments are safe and effective or if they are better than the standard treatment.
What are the outcomes of patients with ATRT?
The prognosis for children with ATRT is bleak. Infants and children under age 3 (at the time of ATRT diagnosis) have a high mortality rate. Children aged 3 and older have a higher survival rate (70%). Patients with ATRT have a median survival period of less than 2 years. Children with metastatic tumors and large tumors have the worst outcomes.
ATRT is resistant to many drugs which is one reason why prognosis is dismal. The discovery and characterization of the rhabdoid tumor predisposition gene on chromosome 22q may allow for the development of more focused, effective therapeutic agents, potentially increasing survival time.
Currently, there is no known cure for ATRT. However, there have recently been dramatic advancements in treatment, and there is growing optimism that these new treatments will soon result in significantly higher survival rates.
Health Solutions From Our Sponsors
Atypical Teratoid Rhabdoid Tumor (ATRT): https://www.stjude.org/disease/atypical-teratoid-rhabdoid-tumor-atrt.html
Atypical Teratoid Rhabdoid Tumor (ATRT) Diagnosis and Treatment: https://www.cancer.gov/rare-brain-spine-tumor/tumors/atrt
Atypical Teratoid / Rhaboid Tumor (AT/RT): https://braintumorcenter.ucsf.edu/condition/atypical-teratoid-rhaboid-tumor-atrt
Atypical Teratoid / Rhaboid Tumor (AT/RT): https://www.braintumourresearch.org/info-support/types-of-brain-tumour/glioma/atypical-teratoid-rhabdoid-tumour-(at-rt)
Top What Are the Symptoms of ATRT? Related Articles
Brain and Spinal Cord Tumors in Adults (Symptoms, Signs, Causes, Treatment Options, Life Expectancy)Brain and spinal tumor are diseases in which cancer (malignant) cells begin to grow in the tissues of the brain. Tumors that start in the brain are called primary brain tumors. Tumors that start in the brain and spread to other organs are called primary brain tumors. Symptoms may include headaches, personality changes, dizziness, and trouble walking. Treatment depends upon the type and grade of tumor.
Brain CancerCancers that form from brain tissue are called primary brain tumors. Brain tumors may be malignant (brain cancer) or benign. Certain risk factors, such as working in an oil refinery, as a chemist, or embalmer, increase the likelihood of developing brain cancer. Symptoms include headaches, weakness, seizures, difficulty walking, blurry vision, nausea,vomiting, and changes in speech, memory, or personality. Treatment may involve surgery, radiation therapy, or chemotherapy.
Brain Cancer: Tumor Signs, Symptoms, and TreatmentBrain cancer, types of which include primary or secondary cancer, involves invasive brain tumors including gliomas and glioblastomas. Learn the brain cancer survival rate, treatment options including chemotherapy, and the different brain tumor grades. Find out how the right treatment plan can fight cancerous brain tissue.
Brain Tumor: Warning Symptoms, Types, Causes, Treatments, and CureA brain tumor can be either non-cancerous (benign) or cancerous (malignant), primary, or secondary. Common symptoms of a primary brain tumor are headaches, seizures, memory problems, personality changes, and nausea and vomiting. Causes and risk factors include age, gender, family history, and exposure to chemicals. Treatment is depends upon the tumor type, grade, and location.
Can Spinal Tumors Affect the Brain?Brain and spinal cord form the central nervous system or CNS. These tumors arise within the skull or the spinal canal (the column that encloses the spinal cord). A spinal tumor is also called an intradural tumor and is an uncontrolled growth of cells developing within the spinal canal or the bones of the spine.
Cancer: What Complications Can Brain Cancer Cause?Brain cancer can cause many different complications, from seizures to extreme fatigue. Use this WebMD slideshow to learn how it can affect your body, and what you and your doctor can do about it.
ChemotherapyChemotherapy is the treatment of cancer with drugs that can destroy cancer cells. These drugs often are called "anticancer" drugs. Chemotherapy is often used with other treatments. Coping with side effects (fatigue, nausea, vomiting, pain, hair loss, infection, diarrhea, constipation, fluid retention, mouth and throat problems) are important to understand when undergoing chemotherapy treatment. It is important to eat well during chemotherapy, and get the support you need both during and after treatment.
Common Infant IllnessesWatch this slideshow to see common symptoms and home treatment for infant and childhood illnesses including fever, nausea, constipation and more.
What Is the Difference Between Tumor Grade and Stage?While tumor grade describes the appearance of cancerous cells, the tumor stage encompasses the tumor’s location, size and extent, number, and whether it has spread.
What Were Your First Signs and Symptoms of a Brain Tumor?The symptoms of a tumor depend on how big it is and where it is in the brain. Some slow-growing tumors may not cause any symptoms at first. Eventually, the tumor may put pressure on the brain that may cause the signs and symptoms like severe headaches, seizures, irritability, dizziness, personality change and more.
Radiation TherapyRadiation therapy is a cancer-fighting technique. In radiation therapy, a radiation oncologist uses high-energy rays to kill cancer cells and stop them from growing and dividing. The two types of radiation therapy are external and internal. Potential side effects of radiation therapy include:
- skin redness,
- permanent pigmentation,
- diarrhea, and
- a reduction in white blood cells.
Targeted Therapy: What Are Invasion and Metastasis in cancer?There are several proteins and cellular signals that cancerous or malignant tumor cells employ for promoting invasion and metastasis. Targeted cancer therapies are in development to chemically hinder invasion and metastasis. Targeted therapy, in general, by identifying and targeting cancer-causing factors. Targeted therapy medications do not directly kill the cancer cells, but work on the cellular level to stop their growth and prevent cancer from spreading to other parts of the body.
Targeted Therapy: What Is Oncogenic Addiction in Cancer Cells?Targeted therapy for cancers with oncogenic addiction aims to stop the mutated "oncogene" that fuels the tumor. Research indicates that cancer cells may rely more heavily on oncogenic mutations that originally gave rise to the particular cancer, rather than other reasons for their growth. Such cancers have an oncogenic addiction because they mainly depend on that oncogene’s continued activity for survival.
Targeted Therapy: What Is Replicative Immortality in Cancer?Some targeted cancer therapies aim to stop replicative immortality in malignant tumor cells. Normal human cells can grow and divide only a limited number of times, and undergo planned death (apoptosis) when they become old, damaged, or no longer needed. Cancer cells, due to genetic mutations which enable them to progress through the cell cycle despite DNA damage, replicate infinitely and evade apoptosis. They achieve replicative immortality (until the host dies).
Targeted Therapy: What Is Apoptosis in Cancer Cells?Cancer cells grow and proliferate endlessly. Targeted therapy to stimulate cell death or apoptosis can help keep tumors in check. Normal cells have a finite cell cycle of growth, division and differentiation. The final stage in the cell cycle is apoptosis, or programmed cell death, when they are infected, old, damaged or simply no longer needed.
Targeted Therapy: What Is the Function of A Tumor Suppressor Gene?Tumor suppressor genes encode proteins to modulate the process of cell growth and replication. Mutations which inactivate the tumor suppressor genes enable cancer cells to grow, unrestrained. Some targeted therapies aim to reactivate these genes, thus suppressing the tumor.
Targeted Therapy: What Are The 10 Hallmarks of Cancer?Targeted cancer therapy is a specialized treatment for certain cancers with medications that target the proteins and cell-signaling pathways in the cancer cells which drive their growth and proliferation. Targeted therapies also aim to stop some of the other mechanisms in the tumor microenvironment which the cancer cells enslave to foster their growth and metastasis.
What Is the Survival Rate of ATRT?According to the National Cancer Institute, the 5-year survival rate for an atypical teratoid rhabdoid tumor (ATRT) is 32.2%, although survival rates vary.